Delhi High Court reserves verdict in challenge to FDC drug ban

Smrithi Suresh June 2 2016
Online Pharmacies

Justice RS Endlaw of the Delhi High Court has reserved judgment on the petitions filed by pharma companies challenging the Health Ministry’s ban on 344 FDC (Fixed Dose Combination) drugs.

Justice Endlaw who has been hearing final arguments in the case for two months now, reserved his orders today on a batch of nearly 300-odd petitions filed by different pharma companies. 

With a premium account you get:
  • One year of unrestrcited access to previous interviews, columns and articles
  • One year access to all archival material
  • Access to all Bar & Bench reports